In the U.S. in the early 1960s the distributor of a thalidomide drug was impatient to get it on the market. But FDA medical ...

Severe nosebleeds caused by hereditary hemorrhagic telangiectasia dwinded in people who took a drug used to treat cancer.

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic ...

Starting with her rejection of an FDA application for thalidomide in 1960, physician and pharmacist Frances Oldham Kelsey took a stand against the now infamous drug ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

Excluding pregnant women from drug trials is standard. But medication use during pregnancy has gone up, and many women are ...

The Government has appointed High Court judge Paul Gilligan to have talks with thalidomide survivors, it has emerged.

The legacy of Thalidomide continues to impact how medications are prescribed to pregnant women today. Ethical concerns, legal ...

Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare ...

Thalidomide survivors have welcomed the government's appointment of Judge Paul Gilligan to begin discussions with survivors.

The coalition leaders have informed the Cabinet of their intention to appoint Mr Justice Paul Gilligan to engage with the ...

Irish Thalidomide Association believes move will ‘bring 63 years, many wasted years of our campaign, to an end’ ...